Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 NOK | -0.95% | -5.45% | -20.61% |
Mar. 14 | Hofseth BioCare ASA Announces Board Changes | CI |
Feb. 09 | Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Business Summary
Number of employees: 60
Sales per Business
NOK in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Salmon Oil (OmeGo)
52.8
%
| 33 | 62.8 % | 43 | 52.8 % | +30.37% |
Non-soluble Protein (PetGo TM)
25.4
%
| 13 | 24.0 % | 21 | 25.4 % | +64.48% |
Soluble Protein Hydrolysate (ProGo)
11.6
%
| 3 | 6.0 % | 10 | 11.6 % | +198.59% |
By-products
6.9
%
| 1 | 2.6 % | 6 | 6.9 % | +308.61% |
Calcium (CalGo)
3.3
%
| 2 | 4.6 % | 3 | 3.3 % | +10.59% |
Sales per region
NOK in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Europe excluding Norway
48.6
%
| 11 | 20.0 % | 40 | 48.6 % | +276.51% |
North America
29.8
%
| 20 | 37.9 % | 25 | 29.8 % | +22.35% |
Norway
16.7
%
| 18 | 34.6 % | 14 | 16.7 % | -24.92% |
Asia
4.8
%
| 4 | 7.4 % | 4 | 4.8 % | +1.12% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jon Olav Ødegård
CEO | Chief Executive Officer | 51 | 13-02-28 |
Roger Hofseth
FOU | Founder | 50 | 99-12-31 |
Crawford Currie
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 63 | 09-12-31 | |
James Berger
IRC | Investor Relations Contact | - | - |
Andy Gill
PRN | Corporate Officer/Principal | - | 20-12-31 |
Kai Morten Thuen
SAM | Sales & Marketing | - | 14-08-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Roger Hofseth
FOU | Founder | 50 | 99-12-31 |
Director/Board Member | 53 | 15-04-30 | |
Director/Board Member | 49 | 15-04-30 | |
Amy Novogratz
BRD | Director/Board Member | - | 21-12-02 |
Crawford Currie
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chairman | - | 20-04-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 395,081,030 | 164,869,381 ( 41.73 %) | 0 | 41.73 % |
Company contact information
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-20.61% | 76.13M | |
-1.61% | 278B | |
-3.22% | 94.39B | |
-1.22% | 44.41B | |
+2.15% | 41.48B | |
+3.90% | 39.56B | |
+6.94% | 39.33B | |
-1.36% | 29.71B | |
+5.07% | 23.78B | |
-9.74% | 22.6B |
- Stock
- Equities
- Stock Hofseth BioCare ASA - Oslo Bors
- Company Hofseth BioCare ASA